Invention Grant
- Patent Title: Method for establishing colorectal cancer HK2 reporter gene cell line
-
Application No.: US16679759Application Date: 2019-11-11
-
Publication No.: US11492597B2Publication Date: 2022-11-08
- Inventor: Hongbing Yu , Xin Liu
- Applicant: Guangdong Medical University
- Applicant Address: CN Dongguan
- Assignee: Guangdong Medical University
- Current Assignee: Guangdong Medical University
- Current Assignee Address: CN Dongguan
- Agency: Dragon Sun Law Firm, PC
- Agent Jinggao Li; Nathaniel Perkins
- Priority: CN201811384392.0 20181120
- Main IPC: C12N5/09
- IPC: C12N5/09 ; C12Q1/6897 ; C12N15/90

Abstract:
The present invention discloses a method for establishing a colorectal cancer HK2 reporter gene cell line, specifically including: firstly, designing a site-specific sgRNA sequence of an HK2 gene, and cloning same into a PX459 plasmid; integrating a homologous recombination sequence of an HK2 gene and a green fluorescent protein DNA fragment (EGFP), and transforming the plasmid and the integrated fragment together into a colorectal cancer cell line HCT116 by electroporation; and performing signal cell screening through a flow cytometer to obtain EGFP-expressing cells, and amplifying a monoclonal cell line; and identifying a positive HK2 reporter gene cell line through PCR identification and Western blot, among screened EGFP-expressing cell lines. The colorectal cancer cell line HK2 gene and EGFP are co-expressed, and the expression level of the EGFP is highly consistent with that of the HK2 gene. Therefore, the expression level of the HK2 gene can be accurately determined by detecting a change in the expression level of the EGFP. The method for establishing a cell line in the present invention are simple, easy to implement and efficient, and a gene site can be precisely positioned.
Public/Granted literature
- US20210130791A1 METHOD FOR ESTABLISHING COLORECTAL CANCER HK2 REPORTER GENE CELL LINE Public/Granted day:2021-05-06
Information query